IFIH1 and myopathy: Furthermore, our study showed that patients with anti-MDA5+ or anti-ARS+ commonly exhibit comorbidity with anti-Ro52 antibodies because Ro52 forms Ro52/IgG/HLA-DR complexes on the cell surface, which are specifically recognized by autoantibodies in some patients with inflammatory myopathies (57).